SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-20-000104
Filing Date
2020-06-08
Accepted
2020-06-08 06:29:04
Documents
16
Period of Report
2020-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-2020x06x08pressrel.htm   iXBRL 8-K 44184
2 EXHIBIT 99 tevalitigationpressrelea.htm EX-99 2851
8 tevalitigationpressrelea001.jpg GRAPHIC 169534
  Complete submission text file 0001367644-20-000104.txt   430164

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20200605.xsd EX-101.SCH 4492
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20200605_cal.xml EX-101.CAL 662
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20200605_def.xml EX-101.DEF 1512
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20200605_lab.xml EX-101.LAB 27268
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20200605_pre.xml EX-101.PRE 14152
14 EXTRACTED XBRL INSTANCE DOCUMENT ebs-2020x06x08pressrel_htm.xml XML 4396
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 20948057
SIC: 2834 Pharmaceutical Preparations